LPAR3 and ovarian cancer: Some of them are widely expressed in various tissues and therefore we suggest using the LPAR3-specific LPA derivative 1-oleoyl-2-methyl-sn-glycero-3-phosphothionate (OMPT) as ovarian cancer targeting ligand.